Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action

Brain Research

Volumn 1601, Issue , 2015, Pages 117-126

  Andreasen, Jesper T ^a   Fitzpatrick, Ciaran M ^a   Larsen, Maria ^a   Skovgaard, Lars ^a   Nielsen, Simon D ^a   Clausen, Rasmus P ^a   Troelsen, Karin ^a   Pickering, Darryl S ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

AMPA receptor; Antidepressants; Anxiety; Cognition; Depression; Glutamate; Mouse behaviour

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; AMPA RECEPTOR; CITALOPRAM; N [2 [4 (4 CYANOPHENYL)PHENYL]PROPYL] 2 PROPANESULFONAMIDE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; SULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; ELEVATED ZERO MAZE TEST; FEMALE; FOOD PREFERENCE; FORCED SWIM TEST; HYPOPHAGIA; LOCOMOTION; LONG TERM MEMORY; MARBLE BURYING TEST; MAZE TEST; MOUSE; NEUROTRANSMISSION; NONHUMAN; NOVELTY INDUCED HYPOPHAGIA; PRIORITY JOURNAL; PROTEIN FUNCTION; TAIL SUSPENSION TEST; TRANQUILIZING ACTIVITY; AGONISTS; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; ANXIETY; CHEMICALLY INDUCED; DEPRESSIVE DISORDER; DRUG EFFECTS; MOTOR ACTIVITY;

RODENTIA;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BENZODIAZEPINES; DEPRESSIVE DISORDER; FEMALE; MAZE LEARNING; MICE; MOTOR ACTIVITY; RECEPTORS, AMPA; SULFONAMIDES;

EID: 84924439661     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2015.01.001     Document Type: Article

References (47)

1. N. Albelda, and D. Joel Animal models of obsessive-compulsive disorder: exploring pharmacology and neural substrates Neurosci. Biobehav. Rev. 36 2012 47 63
2. A. Alt, B. Weiss, A.M. Ogden, X. Li, S.D. Gleason, D.O. Calligaro, D. Bleakman, and J.M. Witkin In vitro and in vivo studies in rats with LY293558 suggest AMPA/kainate receptor blockade as a novel potential mechanism for the therapeutic treatment of anxiety disorders Psychopharmacology (Berl) 185 2006 240 247
3. J.T. Andreasen, M. Gynther, A. Rygaard, T. Bogelund, S.D. Nielsen, R.P. Clausen, J. Mogensen, and D.S. Pickering Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests Neurosci. Lett. 546 2013 6 10
4. J.T. Andreasen, G.M. Olsen, O. Wiborg, and J.P. Redrobe Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests J. Psychopharmacol. 23 2009 797 804
5. J.T. Andreasen, and J.P. Redrobe Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests Behav. Brain Res. 197 2009 150 156
6. D.S. Baldwin, I.M. Anderson, D.J. Nutt, B. Bandelow, A. Bond, J.R. Davidson, J.A. den Boer, N.A. Fineberg, M. Knapp, J. Scott, H.U. Wittchen, and P. British Association for Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology J. Psychopharmacol. 19 2005 567 596
7. D.M. Bannerman, R.M. Deacon, S. Brady, A. Bruce, R. Sprengel, P.H. Seeburg, and J.N. Rawlins A comparison of GluR-A-deficient and wild-type mice on a test battery assessing sensorimotor, affective, and cognitive behaviors Behav. Neurosci. 118 2004 643 647
8. A. Barbon, L. Caracciolo, C. Orlandi, L. Musazzi, A. Mallei, L. La Via, D. Bonini, C. Mora, D. Tardito, M. Gennarelli, G. Racagni, M. Popoli, and S. Barlati Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels Neurochem. Int. 59 2011 896 905
9. S.T. Bate, and R.A. Clark The Design and Statistical Analysis of Animal Experiments 2014 Cambridge University Press
10. L.L. Bi, J. Wang, Z.Y. Luo, S.P. Chen, F. Geng, Y.H. Chen, S.J. Li, C.H. Yuan, S. Lin, and T.M. Gao Enhanced excitability in the infralimbic cortex produces anxiety-like behaviors Neuropharmacology 72 2013 148 156
11. F. Borsini, J. Podhorna, and D. Marazziti Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology (Berl) 163 2002 121 141
12. A. Bystritsky Treatment-resistant anxiety disorders Mol. Psychiatry 11 2006 805 814
13. D.T. Christian, N.J. Alexander, M.R. Diaz, S. Robinson, and B.A. McCool Chronic intermittent ethanol and withdrawal differentially modulate basolateral amygdala AMPA-type glutamate receptor function and trafficking Neuropharmacology 62 2012 2430 2439
14. S.C. Dulawa, and R. Hen Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test Neurosci. Biobehav. Rev. 29 2005 771 783
15. InVivoStat >http://invivostat.co.uka<
16. M. Iijima, S. Kurosu, and S. Chaki Effects of agents targeting glutamatergic systems on marble-burying behavior Neurosci. Lett. 471 2010 63 65
17. E. Izzo, J. Auta, F. Impagnatiello, C. Pesold, A. Guidotti, and E. Costa Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines Proc. Natl. Acad. Sci. USA 98 2001 3483 3488
18. H.P. Kaesermann Stretched attend posture, a non-social form of ambivalence, is sensitive to a conflict-reducing drug action Psychopharmacology (Berl) 89 1986 31 37
19. G.L. Kapus, I. Gacsalyi, M. Vegh, H. Kompagne, E. Hegedus, C. Leveleki, L.G. Harsing, J. Barkoczy, A. Bilkei-Gorzo, and G. Levay Antagonism of AMPA receptors produces anxiolytic-like behavior in rodents: effects of GYKI 52466 and its novel analogues Psychopharmacology (Berl) 198 2008 231 241
20. M. Karcz-Kubicha, and S. Liljequist Evidence for an anxiogenic action of AMPA receptor antagonists in the plus-maze test Eur. J. Pharmacol. 279 1995 171 177
21. C. Kiselycznyk, X. Zhang, R.L. Huganir, A. Holmes, and P. Svenningsson Reduced phosphorylation of GluA1 subunits relates to anxiety-like behaviours in mice Int. J. Neuropsychopharmacol. 16 2013 919 924
22. J. Kotlinska, and S. Liljequist The putative AMPA receptor antagonist, LY326325, produces anxiolytic-like effects without altering locomotor activity in rats Pharmacol. Biochem. Behav. 60 1998 119 124
23. M. Kurt, A.C. Arik, and S. Celik The effects of sertraline and fluoxetine on anxiety in the elevated plus-maze test in mice J. Basic Clin. Physiol. Pharmacol. 11 2000 173 180
24. A.K. Läck, M.R. Diaz, A. Chappell, D.W. DuBois, and B.A. McCool Chronic ethanol and withdrawal differentially modulate pre- and postsynaptic function at glutamatergic synapses in rat basolateral amygdala J. Neurophysiol. 98 2007 3185 3196
25. X. Li, J.P. Tizzano, K. Griffey, M. Clay, T. Lindstrom, and P. Skolnick Antidepressant-like actions of an AMPA receptor potentiator (LY392098) Neuropharmacology 40 2001 1028 1033
26. X. Li, J.M. Witkin, A.B. Need, and P. Skolnick Enhancement of antidepressant potency by a potentiator of AMPA receptors Cell. Mol. Neurobiol. 23 2003 419 430
27. A. Little Treatment-resistant depression Am. Fam. Physician 80 2009 167 172
28. T. Londei, A.M. Valentini, and V.G. Leone Investigative burying by laboratory mice may involve non-functional, compulsive, behaviour Behav. Brain Res. 94 1998 249 254
29. R. Martinez-Turrillas, D. Frechilla, and J. Del Rio Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus Neuropharmacology 43 2002 1230 1237
30. A.N. Mead, H.V. Morris, C.I. Dixon, S.L. Rulten, L.V. Mayne, D. Zamanillo, and D.N. Stephens AMPA receptor GluR2, but not GluR1, subunit deletion impairs emotional response conditioning in mice Behav. Neurosci. 120 2006 241 248
31. Z. Merali, C. Levac, and H. Anisman Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice Biol. Psychiatry 54 2003 552 565
32. C. Mombereau, T.L. Gur, J. Onksen, and J.A. Blendy Differential effects of acute and repeated citalopram in mouse models of anxiety and depression Int. J. Neuropsychopharmacol. 13 2010 321 334
33. L. Musazzi, G. Treccani, A. Mallei, and M. Popoli The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors Biol. Psychiatry 73 2013 1180 1188
34. J.P. Redrobe, E.O. Nielsen, J.K. Christensen, D. Peters, D.B. Timmermann, and G.M. Olsen Alpha7 nicotinic acetylcholine receptor activation ameliorates scopolamine-induced behavioural changes in a modified continuous Y-maze task in mice Eur. J. Pharmacol. 602 2009 58 65
35. C. Riaza Bermudo-Soriano, M.M. Perez-Rodriguez, C. Vaquero-Lorenzo, and E. Baca-Garcia New perspectives in glutamate and anxiety Pharmacol. Biochem. Behav. 100 2012 752 774
36. T.W. Robbins, and E.R. Murphy Behavioural pharmacology: 40+ years of progress, with a focus on glutamate receptors and cognition Trends Pharmacol. Sci. 27 2006 141 148
37. S. Rosenzweig-Lipson, C.E. Beyer, Z.A. Hughes, X. Khawaja, S.J. Rajarao, J.E. Malberg, Z. Rahman, R.H. Ring, and L.E. Schechter Differentiating antidepressants of the future: efficacy and safety Pharmacol. Ther. 113 2007 134 153
38. G. Sanacora, G. Treccani, and M. Popoli Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders Neuropharmacology 62 2012 63 77
39. G. Sanchez-Andrade, B.M. James, and K.M. Kendrick Neural encoding of olfactory recognition memory J. Reprod. Dev. 51 2005 547 558
40. D.J. Sanderson, M.A. Good, P.H. Seeburg, R. Sprengel, J.N. Rawlins, and D.M. Bannerman The role of the GluR-A (GluR1) AMPA receptor subunit in learning and memory Prog. Brain Res. 169 2008 159 178
41. J.K. Shepherd, S.S. Grewal, A. Fletcher, D.J. Bill, and C.T. Dourish Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety Psychopharmacology (Berl) 116 1994 56 64
42. L.I. Sinclair, D.M. Christmas, S.D. Hood, J.P. Potokar, A. Robertson, A. Isaac, S. Srivastava, D.J. Nutt, and S.J. Davies Antidepressant-induced jitteriness/anxiety syndrome: systematic review Br. J. Psychiatry 194 2009 483 490
43. P. Skolnick, R.T. Layer, P. Popik, G. Nowak, I.A. Paul, and R. Trullas Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression Pharmacopsychiatry 29 1996 23 26
44. N. Sousa, O.F. Almeida, and C.T. Wotjak A hitchhiker's guide to behavioral analysis in laboratory rodents Genes Brain Behav. 5 Suppl 2 2006 5 24
45. Y. Tizabi, B.H. Bhatti, K.F. Manaye, J.R. Das, and L. Akinfiresoye Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar-Kyoto rats Neuroscience 213 2012 72 80
46. C.C. Wrenn, A.P. Harris, M.C. Saavedra, and J.N. Crawley Social transmission of food preference in mice: methodology and application to galanin-overexpressing transgenic mice Behav. Neurosci. 117 2003 21 31
47. X. Xiang, W. Huang, C.N. Haile, and T.A. Kosten Hippocampal GluR1 associates with behavior in the elevated plus maze and shows sex differences Behav. Brain Res. 222 2011 326 331